from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0336/-

LFCtreatmentdescriptionclass of inhibitor

-0.177

Amikacinug/mL Amikacintranslation

0.073

Cap5-10ug/mL Capreomycintranslation

-0.139

Rox10-50 ug/mL Roxithromycintranslation

-0.555

SM2-5 ug/mL Streptomycintranslation

0.653

Tet5-10 ug/mL Tetracyclinetranslation

-0.431

Rif0.2-5ug/mL Rifampicintranscription

-0.258

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.354

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.258

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.165

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.027

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.575

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.419

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.260

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.112

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.713

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.548

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.334

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.878

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.477

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.519

KCN5-20 ug/mL Potassium cyaniderespiration

-0.177

NaN30.2-2 mM Sodium aziderespiration

-0.082

Nigericin50 uM Nigericinrespiration

0.035

TRC10-150 ug/mL Triclosanrespiration

-0.244

TRZ10-25 ug/mL Thioridazinerespiration

0.422

Valinomycin0.5-10 uM Valinomycinrespiration

1.743

ZnSO42 mM ZnSO4respiration

-0.362

menadione6-10 ug/mL Menadionerespiration

-0.643

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.463

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.451

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.501

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.654

NRP_1Non-replicating persistence stage 1dosRassociated

-0.482

Amp0.2mg/mL AmpicillincellWall

-0.464

Cephalexin20-100 ug/mL CephalexincellWall

-0.550

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.124

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.404

EMB10-20 ug/mL EthambutolcellWall

-0.590

Eta12-40 ug/mL EthionamidecellWall

-0.332

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.672

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.785

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.934

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.135

BZA0.12 mg/mL BenzamidearomaticAmides

0.137

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.028

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.940

H2O24 mM hydrogen peroxideDNAdamaging

1.499

Levo10 ug/mL LevofloxacinDNAdamaging

0.958

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.497

Novobiocin10 ug/mL NovobiocinDNAdamaging

2.441

Oflox5-10 ug/mL OfloxacinDNAdamaging

2.476

UVUV-irradiationDNAdamaging

-0.476

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.392

Antimycin12.5-50 ug/mL Antimycin A?

-0.641

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.500

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.728

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.548

PA8240.2-2 ug/mL PA-824?

0.497

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.200

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.317

Verapamil50 uM Verapamil?

-0.527

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.578

methoxatin10-20 ug/mL Methoxatin?